VALIDATION AND APPLICATION OF RP-HPLC METHOD FOR QUANTIFICATION OF ENROFLOXACIN IN PURE AND VETERINARY DOSAGE FORMS

Authors

  • ASWATHY S. R. Department of Pharmaceutical Analysis, KTN College of Pharmacy, Chalavara, Puliyanamkunnu (PO), Ottappalam, Palakkad 698505, Kerala https://orcid.org/0000-0002-8792-8623
  • MUHAS C. Department of Pharmaceutical Analysis, KTN College of Pharmacy, Chalavara, Puliyanamkunnu (PO), Ottappalam, Palakkad 698505, Kerala https://orcid.org/0000-0002-3151-6742
  • ANJALI SRUTHY S. Department of Pharmaceutical Analysis, KTN College of Pharmacy, Chalavara, Puliyanamkunnu (PO), Ottappalam, Palakkad 698505, Kerala, India
  • DEVI SWAPNA P. V. Department of Pharmaceutical Analysis, KTN College of Pharmacy, Chalavara, Puliyanamkunnu (PO), Ottappalam, Palakkad 698505, Kerala, India
  • GOPINATH U. Department of Pharmaceutical Analysis, KTN College of Pharmacy, Chalavara, Puliyanamkunnu (PO), Ottappalam, Palakkad 698505, Kerala, India

DOI:

https://doi.org/10.22159/ijpps.2022v14i2.43053

Keywords:

Enrofloxacin, Method development, Method validation, RP-HPLC

Abstract

Objective: The main objective of this study is to develop and validate a simple, new, fast, sensitive, precise and accurate RP-HPLC analytical methods have been established for the estimation of enrofloxacin in bulk and pharmaceutical dosage forms.
Methods: The present method was developed and validated on a Waters HPLC system using Phenomenex make Shimadzu C18 column (250 mm × 4.6 mm i.d., 5μm particle size) column was used for the separation. Best results were obtained with the mobile phase composition consisting of Acetonitrile-water (80:20, v/v). The system was regulated at 1.0 ml/min flow rate at 270 nm UV detection.
Results: Enrofloxacin was eluted at 3.405 min retention time. The analytical parameters such as accuracy, precision, linearity, LOD, LOQ, ruggedness, and robustness were used for validating the developed method according to ICH guidelines. Linearity was exhibited over the concentration range of 0.1-0.6µg/ml and the Limit of Detection and Quantitation values for Enrofloxacin was 0.001µg/ml and 0.03µg/ml, respectively. The result of the analysis shows that the amount of drugs present in the formulation has a very good correlation with the label claim of the formulation and %RSD will be less than 2 for all the validation parameters. Recoveries studies revealed that results within the specified limits.
Conclusion: The developed methods were validated for various parameters as per ICH guidelines. Hence the proposed method was found to be satisfactory and could be used for the routine analysis of enrofloxacin in their marketed formulation.

Downloads

Download data is not yet available.

References

Hooper DC, Wolfson JS. Quinolone antimicrobial agents. 2nd ed. London: Penguin; 1993. p. 59-75.

Brown SA. Fluoroquinolones in animal health. J Vet Pharmacol Ther. 1996;19(1):1-14. doi: 10.1111/j.1365-2885.1996.tb00001.x, PMID 8992019.

Elmas M, Tras B, Kaya S, Bas AL, Yazar E, Yarsan E. Pharmacokinetics of enrofloxacin after intravenous and intramuscular administration in Angora goats. Can J Vet Res. 2001;65(1):64-7. PMID 11227198.

Riviere J, Craigmill AL, Sundlo SF. Handbook of comparative pharmacokinetics and residues of veterinary antimicrobials. Boca Raton, FL: CRC Press Press; 1991. p. 339-407.

Prescott JF, Baggott JD. editors. Antimicrobial therapy in veterinary medicine. Vol. 2. Ames, IA: Iowa State University Press; 1993. p. 119-26.

Plumb DC. Veterinary drug handbook. Pharma Vet Publishing; 1991. p. 520-9.

Imre S, Dogaru MT, Vari CE, Muntean T, Kelemen L. Validation of an HPLC method for the determination of ciprofloxacin in human plasma. J Pharm Biomed Anal. 2003;33(1):125-30. doi: 10.1016/s0731-7085(03)00151-1. PMID 12946539.

Garcia MA, Solans C, Aramayona JJ, Rueda S, Bregante MA, de Jong A. Simultaneous determination of enrofloxacin and its primary metabolite, ciprofloxacin, in plasma by HPLC with fluorescence detection. Biomed Chromatogr. 1999;13(5):350-3. doi: 10.1002/(SICI)1099-0801(199908)13:5<350:AID-BMC889>3.0.CO;2-C, PMID 10425026.

Mostafa S, El-sadek M, alla EA. Spectrophotometric determination of enrofloxacin and pefloxacin through ion-pair complex formation. J Pharm Biomed Anal. 2002;28(1):173-80. doi: 10.1016/s0731-7085(01)00591-x, PMID 11861121.

Gigosos PG, Revesado PR, Cadahía O, Fente CA, Vazquez BI, Franco CM, Cepeda A. Determination of quinolones in animal tissues and eggs by high-performance liquid chromatography with photodiode-array detection. J Chromatogr A. 2000;871(1-2):31-6. doi: 10.1016/S0021-9673(99)01048-1.

Patel KM, Suhagia BN, Singhvi I. Analytical method development and validation for enrofloxacin in bulk and formulation by RP-HPLC method. AJPTR 2018;8(2):176-85. doi: 10.46624/ajptr.2018.v8.i2.013.

da Silva Anacleto S, Teixeira LS, Borges MMC, Moraes CT, de Souza Borges W, Pereira AC, Borges KB. A simple and rapid HPLC method for the multidetermination of enrofloxacin, ciprofloxacin, and oxytetracyclin in raw materials and veterinary pharmaceutical formulations. Curr Pharm Anal. 2018;14(4):397-404. doi: 10.2174/1573412913666170613091914.

Brahma Reddy, DR Reddy, DPK Konda B. Method development and validation for estimation of enrofloxacin by RP-LC in marketed formulations. Int J Pharm Sci Lett. 2015;5:624-6.

Tauber VP, Chiurciu V. Development and validation of an HPLC method for the determination of oxytetracycline and enrofloxacin in veterinary formulations. Medicam Vet Vet Drug. 2015;9:65-9.

Prasad KB, Murthy TGK. Analytical method development and validation for the estimation of enrofloxacin in small-volume parenteral formulation by HPLC method. J Pharm Res. 2010;3:1128-30.

Souza MJ, Bittencourt CF, Morsch LM. LC determination of enrofloxacin. J Pharm Biomed Anal. 2002;28(6):1195-9. doi: 10.1016/s0731-7085(01)00673-2, PMID 12049983.

Sumithra S, PS, VR. Quality by design-based optimization and validation of new reverse phase-high-performance liquid chromatography method for simultaneous estimation of levofloxacin hemihydrate and ambroxol hydrochloride in bulk and its pharmaceutical dosage form. Asian J Pharm Clin Res. 2016;9(9):190-6. doi: 10.22159/ajpcr.2016.v9s3.14040.

Krishna KJ, Prasada RK. Novel validated headspace gas chromatography method for the simultaneous quantification of three volatile organic impurities in enrofloxacin pure and pharmaceutical dosage forms. Asian J Pharm Clin Res. 2020;13(11):171-7.

Richez P, Monlouis JD, Dellac D, Daube G. Validation of a therapeutic regimen for enrofloxacin in cats on the basis of pharmacokinetic data. J Vet Pharmacol Ther. 1997;20(10):152-3.

International conference on harmonization. ICH harmonized tripartite guideline. Validation of Analytical Procedures: Text and Methodology. Vol. Q2; 2005. p. R1.

US Food and Drug Administration. Guidance for industry. Silver Spring, MD: Analytical Procedures and Methods Validation for Drugs and Biologics, US Food and Drug Administration; 2015.

Published

01-02-2022

How to Cite

S. R., A., M. C., A. SRUTHY S., D. S. P. V., and G. U. “VALIDATION AND APPLICATION OF RP-HPLC METHOD FOR QUANTIFICATION OF ENROFLOXACIN IN PURE AND VETERINARY DOSAGE FORMS”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 14, no. 2, Feb. 2022, pp. 42-47, doi:10.22159/ijpps.2022v14i2.43053.

Issue

Section

Original Article(s)